1-10 of 10
lead
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neighborhood Socioeconomic Environment and Risk of Type 2 Diabetes: Associations and Mediation Through Food Environment Pathways in Three Independent Study Samples

Lorna E. Thorpe, Samrachana Adhikari, Priscilla Lopez, Rania Kanchi, Leslie A. McClure, Annemarie G. Hirsch, Carrie R. Howell, Aowen Zhu, Farrokh Alemi, Pasquale Rummo, Elizabeth L. Ogburn, Yasemin Algur, Cara M. Nordberg, Melissa N. Poulsen, Leann Long, April P. Carson, Shanika A. DeSilva, Melissa Meeker, Brian S. Schwartz, David C. Lee, Karen R. Siegel, Giuseppina Imperatore, Brian Elbel
Journal: Diabetes Care
Diabetes Care 2022;45(4):798–810
https://doi.org/10.2337/dc21-1693
Published: 01 February 2022
View article titled, Neighborhood Socioeconomic Environment and Risk of Type 2 Diabetes: Associations and Mediation Through Food Environment Pathways in Three Independent Study Samples
Open the PDF for Neighborhood Socioeconomic Environment and Risk of Type 2 Diabetes: Associations and Mediation Through Food Environment Pathways in Three Independent Study Samples in another window
Journal Articles

Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women

Guo-Chong Chen, Rhonda Arthur, Victor Kamensky, Jin Choul Chai, Bing Yu, Aladdin H. Shadyab, Matthew Allison, Yangbo Sun, Nazmus Saquib, Robert A. Wild, Wei Bao, Andrew J. Dannenberg, Thomas E. Rohan, Robert C. Kaplan, Sylvia Wassertheil-Smoller, Qibin Qi
Journal: Diabetes Care
Diabetes Care 2022;45(1):222–231
https://doi.org/10.2337/dc21-1565
Published: 03 November 2021
View article titled, Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women
Open the PDF for Body Fat Distribution, Cardiometabolic Traits, and Risk of Major Lower-Extremity Arterial Disease in Postmenopausal Women in another window
Journal Articles

Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes

Mathilde Nativel, Fabrice Schneider, Pierre-Jean Saulnier, Elise Gand, Stéphanie Ragot, Olivier Meilhac, Philippe Rondeau, Elena Burillo, Maxime Cournot, Louis Potier, Gilberto Velho, Michel Marre, Ronan Roussel, Vincent Rigalleau, Kamel Mohammedi, Samy Hadjadj
Journal: Diabetes Care
Diabetes Care 2018;41(10):2162–2169
https://doi.org/10.2337/dc18-0695
Published: 02 August 2018
View article titled, Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes
Open the PDF for Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide

Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Anton Pottegård, Filip Krag Knop, Henrik Toft Sørensen
Journal: Diabetes Care
Diabetes Care 2018;41(9):e133–e135
https://doi.org/10.2337/dc18-0999
Published: 12 July 2018
View article titled, Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
Open the PDF for Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide in another window
Journal Articles

Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonists

Giorgio Sesti, MD
Journal: Diabetes Care
Diabetes Care 2011;34(Supplement_2):S272–S275
https://doi.org/10.2337/dc11-s228
Published: 22 April 2011
View article titled, Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: <subtitle>Glucagon-like peptide 1 agonists</subtitle>
Open the PDF for Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: <subtitle>Glucagon-like peptide 1 agonists</subtitle> in another window
Journal Articles

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, MD, John Gerich, MD, John B. Buse, MD, PHD, Andrew Lewin, MD, Sherwyn Schwartz, MD, Philip Raskin, MD, Paula M. Hale, PHD, Milan Zdravkovic, PHD, Lawrence Blonde, MD, the LEAD-4 Study Investigators
Journal: Diabetes Care
Diabetes Care 2009;32(7):1224–1230
https://doi.org/10.2337/dc08-2124
Published: 16 March 2009
View article titled, Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Open the PDF for Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) in another window
Includes: Supplementary data
Journal Articles

Influence of Health Care Providers on the Development of Diabetes Complications: Long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study

Janice C. Zgibor, PHD, Thomas J. Songer, PHD, Sheryl F. Kelsey, PHD, Allan L. Drash, MD, Trevor J. Orchard, MD
Journal: Diabetes Care
Diabetes Care 2002;25(9):1584–1590
https://doi.org/10.2337/diacare.25.9.1584
Published: 01 September 2002
View article titled, Influence of Health Care Providers on the Development of Diabetes Complications: <subtitle>Long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study</subtitle>
Open the PDF for Influence of Health Care Providers on the Development of Diabetes Complications: <subtitle>Long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study</subtitle> in another window
Journal Articles

Lipid and Blood Pressure Treatment Goals for Type 1 Diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study

Trevor J. Orchard, MBBCH, MMEDSCI, Kimberly Y.-Z. Forrest, PHD, Lewis H. Kuller, MD, Dorothy J. Becker, MBBCH
Journal: Diabetes Care
Diabetes Care 2001;24(6):1053–1059
https://doi.org/10.2337/diacare.24.6.1053
Published: 01 June 2001
View article titled, Lipid and Blood Pressure Treatment Goals for Type 1 Diabetes: <subtitle>10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study </subtitle>
Open the PDF for Lipid and Blood Pressure Treatment Goals for Type 1 Diabetes: <subtitle>10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study </subtitle> in another window
Journal Articles

Assessment of Peripheral Vascular Disease in Diabetes: Report and Recommendations of an International Workshop Sponsored by the American Heart Association and the American Diabetes Association

Trevor J Orchard, MD, D Eugene Strandness, Jr, MD
Journal: Diabetes Care
Diabetes Care 1993;16(8):1199–1209
https://doi.org/10.2337/diacare.16.8.1199
Published: 01 August 1993
View article titled, Assessment of Peripheral Vascular Disease in Diabetes: Report and Recommendations of an International Workshop Sponsored by the American Heart Association and the American Diabetes Association
Open the PDF for Assessment of Peripheral Vascular Disease in Diabetes: Report and Recommendations of an International Workshop Sponsored by the American Heart Association and the American Diabetes Association in another window
Journal Articles

Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective

Richard P Donahue, PHD, Trevor J Orchard, MBBCH, MMEDSCI
Journal: Diabetes Care
Diabetes Care 1992;15(9):1141–1155
https://doi.org/10.2337/diacare.15.9.1141
Published: 01 September 1992
View article titled, Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective
Open the PDF for Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective in another window